Production (Stage)
The Oncology Institute, Inc.
TOI
$3.02
$0.031.00%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 1.53% | 29.71% | 7.50% | 8.39% | 33.70% |
| Total Depreciation and Amortization | 19.81% | 8.24% | -7.36% | 14.22% | 17.34% |
| Total Amortization of Deferred Charges | 212.64% | 1.40% | 1.34% | 1.36% | 2.36% |
| Total Other Non-Cash Items | 30.35% | -74.69% | -66.81% | -96.01% | -77.68% |
| Change in Net Operating Assets | 214.53% | 97.55% | 1,131.77% | -289.12% | 42.81% |
| Cash from Operations | 68.60% | 207.53% | 109.86% | -80.83% | -2.79% |
| Capital Expenditure | 46.23% | -103.83% | 143.23% | -94.88% | 66.83% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -100.00% | 15.75% | -33.64% | -1.20% |
| Cash from Investing | -101.04% | -115.09% | 34.93% | -27.01% | 5.36% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -1,901.58% | 64.44% | -61.38% | 99.34% | 22.23% |
| Issuance of Common Stock | 21,127.40% | -100.00% | -100.00% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -27.65% | 61.56% | -511.43% | -- |
| Cash from Financing | -405.33% | 90.79% | 67.86% | 17.45% | 45.11% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -486.83% | -61.92% | 908.99% | -97.30% | 107.02% |